Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]

Documenti analoghi

• Future possibilities in the prevention of breast cancer: Intervention strategies in BRCA1 and BRCA2 mutation carriers
  di: Eeles, Rosalind A
  Pubblicazione: (2000)
• Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
  di: Bancroft, Elizabeth K., et al.
  Pubblicazione: (2014)
• Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic"
  di: Ardern-Jones, Audrey, et al.
  Pubblicazione: (2004)
• The role of BRCA1 and BRCA2 in prostate cancer
  di: Castro, Elena, et al.
  Pubblicazione: (2012)
• Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
  di: McKinley, Joanne M, et al.
  Pubblicazione: (2007)